Healthcare ❯ Pharmaceuticals ❯ Drug Approval ❯ FDA Regulations
The $1.5 billion pre‑launch cache signals a bid to avoid past GLP‑1 supply gaps ahead of an expected spring FDA ruling on the once‑daily pill.
